| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/01.SLA.0000218089.61635.5F |
| P698 | PubMed publication ID | 16794395 |
| P2093 | author name string | Bruno Chauffert | |
| Michel Simonet | |||
| Patrick Rat | |||
| Philippe Moretto | |||
| Laurent Benoit | |||
| Guy Magnin | |||
| Maria Dolores Ynsa | |||
| Philippe Pointaire | |||
| Philippe Esquis | |||
| Jean-Luc Beltramo | |||
| Carole Drogoul | |||
| David Consolo | |||
| P2860 | cites work | High interstitial fluid pressure - an obstacle in cancer therapy | Q29619719 |
| Pre-clinical study of the epinephrine-cisplatin association for the treatment of intraperitoneal carcinomatosis | Q30657195 | ||
| Successful management of microscopic residual disease in large bowel cancer | Q33651971 | ||
| Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer | Q34055165 | ||
| Intraperitoneal antineoplastic drug delivery: rationale and results | Q35121705 | ||
| Rationale supporting the use of vasoconstrictors for intraperitoneal chemotherapy with platinum derivatives | Q35563294 | ||
| Primary ovarian cancer chemotherapy: current standards of care | Q35602173 | ||
| Increases in intra-abdominal pressure affect pulmonary compliance | Q39380505 | ||
| Cardiovascular, pulmonary, and renal effects of massively increased intra-abdominal pressure in critically ill patients. | Q39527058 | ||
| Prevention of peritoneal carcinomatosis from colon cancer cell seeding using a pirarubicin solution in rats and nude mice | Q40566647 | ||
| Peritoneal-plasma barrier. | Q41146001 | ||
| Quantitative mapping of platinum and essential trace metal in cisplatin resistant and sensitive human ovarian adenocarcinoma cells | Q41231258 | ||
| Interstitial fluid pressure in human melanoma xenografts. Relationship to fractional tumor water content, tumor size, and tumor volume-doubling time | Q41393272 | ||
| Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer | Q41673474 | ||
| Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy | Q44680337 | ||
| Adverse consequences of increased intra-abdominal pressure on bowel tissue oxygen | Q44809563 | ||
| Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy | Q44969242 | ||
| Interstitial hypertension in head and neck tumors in patients: correlation with tumor size. | Q47414414 | ||
| Convection enhanced delivery for the treatment of malignant gliomas: symposium review | Q48872031 | ||
| Epinephrine enhances penetration and anti-cancer activity of local cisplatin on rat sub-cutaneous and peritoneal tumors. | Q50518842 | ||
| Interaction between two cellular subpopulations of a rat colonic carcinoma when inoculated to the syngeneic host. | Q52829628 | ||
| Pressure regulation in the microcirculation | Q52868066 | ||
| Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. | Q53286355 | ||
| Abdominal distension alters regional pleural pressures and chest wall mechanics in pigs in vivo | Q67964263 | ||
| [Experimental chemotherapy of peritoneal carcinomatosis of colonic origin in rats] | Q68120510 | ||
| Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment | Q68723890 | ||
| Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy | Q69609509 | ||
| Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration | Q71665902 | ||
| Barriers to drug delivery in solid tumors | Q72141985 | ||
| Carcinomatosis--is cure an option? | Q73063051 | ||
| Splanchnic ischemia and bacterial translocation in the abdominal compartment syndrome | Q73924902 | ||
| A new abdominal cavity chamber to study the impact of increased intra-abdominal pressure on microcirculation of gut mucosa by using video microscopy in rats | Q74579168 | ||
| Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer | Q79150738 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cisplatin | Q412415 |
| peritoneal carcinomatosis | Q2071182 | ||
| P304 | page(s) | 106-112 | |
| P577 | publication date | 2006-07-01 | |
| P1433 | published in | Annals of Surgery | Q4767866 |
| P1476 | title | High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis | |
| P478 | volume | 244 |
| Q53823792 | A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis. |
| Q44686824 | Activity of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: preliminary clinical experience. |
| Q35295915 | Administration of substances to laboratory animals: routes of administration and factors to consider. |
| Q34253425 | Analyzing intra-abdominal pressures and outcomes in patients undergoing emergency laparotomy |
| Q83498250 | Appraisal of peritoneal cavity's capacity in order to assess the pharmacology of liquid chemotherapy solution in hyperthermic intraperitoneal chemotherapy |
| Q97587435 | Ascites-induced compression alters the peritoneal microenvironment and promotes metastatic success in ovarian cancer |
| Q33920966 | Closed hyperthermic intraperitoneal chemotherapy with open abdomen: a novel technique to reduce exposure of the surgical team to chemotherapy drugs |
| Q37635345 | Cytotoxic effect of different treatment parameters in pressurized intraperitoneal aerosol chemotherapy (PIPAC) on the in vitro proliferation of human colonic cancer cells |
| Q48533666 | Distribution pattern and penetration depth of doxorubicin after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a postmortem swine model |
| Q35098085 | Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment |
| Q64063210 | Establishment of a rat ovarian peritoneal metastasis model to study pressurized intraperitoneal aerosol chemotherapy (PIPAC) |
| Q92617968 | Experimental pharmacokinetics evaluation of chemotherapy delivery by PIPAC for colon cancer: first evidence for efficacy |
| Q91781537 | Exploring the Use of Pegylated Liposomal Doxorubicin (Caelyx®) as Pressurized Intraperitoneal Aerosol Chemotherapy |
| Q37694182 | Feasibility and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis: A Retrospective Cohort Study. |
| Q64933860 | Feasibility, Safety, and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis: A Registry Study. |
| Q36092295 | High-pressure intrapleural chemotherapy: feasibility in the pig model |
| Q36758933 | Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Methodology, Drugs and Bidirectional Chemotherapy |
| Q47109168 | Inflammatory Response and Toxicity After Pressurized IntraPeritoneal Aerosol Chemotherapy. |
| Q37594150 | Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. |
| Q35739551 | Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study |
| Q49118164 | Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence |
| Q53084459 | Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series. |
| Q57150203 | Modeling the effect of ascites-induced compression on ovarian cancer multicellular aggregates |
| Q92617950 | Modelling drug transport during intraperitoneal chemotherapy |
| Q43119082 | Ovarian carcinomatosis in a dog managed with surgery and intraperitoneal, systemic, and intrapleural chemotherapy utilizing indwelling pleural access ports |
| Q92255092 | Overcoming Drug Resistance by Taking Advantage of Physical Principles: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) |
| Q64992742 | Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study. |
| Q41132998 | Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer |
| Q92617940 | Pharmacological principles of intraperitoneal and bidirectional chemotherapy |
| Q92618103 | Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rati |
| Q52579981 | Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for the treatment of malignant mesothelioma. |
| Q27313250 | Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis. |
| Q90655316 | Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastases of pancreas and biliary tract cancer |
| Q89459821 | Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study |
| Q41822485 | Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects. |
| Q48048628 | Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: A phase 2 study |
| Q38253577 | Pressurized intraperitoneal chemotherapy (PIPAC) in women with gynecologic malignancies: a review |
| Q47166165 | Principles and Innovations in Peritoneal Surface Malignancy Treatment |
| Q92226266 | Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, pha |
| Q36851100 | Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis |
| Q38712794 | Scintigraphic peritoneography reveals a non-uniform (99m)Tc-Pertechnetat aerosol distribution pattern for Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a swine model |
| Q52715924 | Severe peritoneal sclerosis after repeated pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC OX): report of two cases and literature survey. |
| Q42654442 | Staged laparoscopic adjuvant intraperitoneal chemohyperthermia after complete resection for locally advanced colorectal or gastric cancer: a preliminary experience. |
| Q33416610 | Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancy |
| Q61795888 | Variation in Clinical Application of Hyperthermic Intraperitoneal Chemotherapy: A Review |
| Q83393453 | [Rationale for perioperative chemotherapy treatment in peritoneal carcinomatosis] |
Search more.